100 related articles for article (PubMed ID: 21969952)
1. [Drug industry and publication practice].
Møller N; Pedersen L
Ugeskr Laeger; 2011 Aug; 173(33):1989. PubMed ID: 21969952
[No Abstract] [Full Text] [Related]
2. [Control should be counteracted].
Gøtzsche PC
Ugeskr Laeger; 2011 Aug; 173(33):1991. PubMed ID: 21969953
[No Abstract] [Full Text] [Related]
3. How honest can a medical journal be?
Groves T
Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):2-3. PubMed ID: 16441685
[No Abstract] [Full Text] [Related]
4. [Conflict of interest and credibility].
Lunde IM
Ugeskr Laeger; 2011 Apr; 173(16-17):1223; author reply 1223. PubMed ID: 21657097
[No Abstract] [Full Text] [Related]
5. Exenatide for the treatment of type 2 diabetes mellitus.
Ruddock B
Issues Emerg Health Technol; 2005 Aug; (71):1-4. PubMed ID: 16389694
[TBL] [Abstract][Full Text] [Related]
6. [Why this arrogance, Josef Milerad?].
Olin GA
Lakartidningen; 2003 Jan; 100(4):254-5. PubMed ID: 12580016
[No Abstract] [Full Text] [Related]
7. If it's too good to be true, it probably is.
Kennedy MS
Am J Nurs; 2009 Dec; 109(12):7. PubMed ID: 19935148
[No Abstract] [Full Text] [Related]
8. Sponsorship, authorship, and accountability.
Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke AJ; Sox HC; Van Der Weyden MB; Wilkes MS
N Engl J Med; 2001 Sep; 345(11):825-6; discussion 826-7. PubMed ID: 11556304
[No Abstract] [Full Text] [Related]
9. Journal withdraws article after complaints from drug manufacturers.
Hawkes N
BMJ; 2011 Apr; 342():d2335. PubMed ID: 21482597
[No Abstract] [Full Text] [Related]
10. Setting the RECORD Straight.
Nissen SE
JAMA; 2010 Mar; 303(12):1194-5. PubMed ID: 20332408
[No Abstract] [Full Text] [Related]
11. [Shoot the messenger!--or the art of changing the subject of conversation].
Zackrisson B
Lakartidningen; 2003 Jan; 100(4):252-3. PubMed ID: 12580015
[No Abstract] [Full Text] [Related]
12. [Ghostwriting].
Haug C
Tidsskr Nor Laegeforen; 2008 May; 128(9):1039. PubMed ID: 18451881
[No Abstract] [Full Text] [Related]
13. Focus on the funding and production of evidence rather than its publication.
Sheldon T
PLoS Med; 2005 Jul; 2(7):e222. PubMed ID: 16033316
[No Abstract] [Full Text] [Related]
14. [The journals must honestly tell who is doing the job].
Bergström R
Lakartidningen; 2008 May 7-13; 105(19):1406-7. PubMed ID: 18574981
[No Abstract] [Full Text] [Related]
15. BIM-51077, a dipeptidyl peptidase-IV-resistant glucagon-like peptide-1 analog.
Giannoukakis N
Curr Opin Investig Drugs; 2007 Oct; 8(10):842-8. PubMed ID: 17907061
[TBL] [Abstract][Full Text] [Related]
16. [Transparency, reliability and conflict of interest].
Lunde IM; Gøtzsche PC
Ugeskr Laeger; 2011 Aug; 173(33):1989. PubMed ID: 21969951
[No Abstract] [Full Text] [Related]
17. [Antidiabetics and the incretin system].
Høibraaten E; Folkersen J
Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1985. PubMed ID: 18787580
[No Abstract] [Full Text] [Related]
18. Insulin treatment for type 2 diabetes: when to start, which to use.
Hamaty M
Cleve Clin J Med; 2011 May; 78(5):332-42. PubMed ID: 21536829
[TBL] [Abstract][Full Text] [Related]
19. [How strict should editors be? Nothing is done for the sake of errors].
Eklund J
Lakartidningen; 2004 Dec; 101(51-52):4250. PubMed ID: 15658596
[No Abstract] [Full Text] [Related]
20. [Freedom of expression and editorial independence: Four firings and a Kafkanian process].
Gøtzsche PC
Ugeskr Laeger; 2008 Apr; 170(18):1537-8. PubMed ID: 18454921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
